Articles From: ZIOPHARM Reports Second-Quarter 2014 Financial Results and Reviews Recent Activities to Regulus to Present at the Wedbush Life Sciences Management Access Conference


TEMPE, Ariz.
Sign-up for Amtech Reports Third Quarter Fiscal 2014 Results investment picks
-Operating Costs Drop 19.8%- -Industrial Supply Net Sales Increase 7.4%- -Cash Position Increases while Debt Decreases $2.1 Million- SHERMAN OAKS, Calif.
Sign-up for Signature Group Holdings, Inc. Reports Second Quarter 2014 Results investment picks
MILL VALLEY, Calif.
Sign-up for Redwood Trust Declares $0.28 Per Share Dividend For The Third Quarter Of 2014 investment picks
Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED ® technology and materials, today reported financial results for the second quarter ended June 30, 2014.
Sign-up for Universal Display Corporation Announces Second Quarter 2014 Financial Results investment picks
MONROE, La.
Sign-up for CenturyLink to Participate in Analyst Conferences investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961646001&sourceType=1 http://www.ccnmatthews.com/logos2/senvest.jpg MONTREAL, QUEBEC --
Sign-up for Senvest Capital Inc. Reports Results for the Second Quarter Ended June 30, 2014 investment picks
Kemper Corporation (NYSE: KMPR) reported today net income of $9.3 million, or $0.17 per diluted share, for the second quarter of 2014, compared to $34.0 million, or $0.59 per diluted share, for the second quarter of 2013.
Sign-up for Kemper Corporation Reports Second Quarter 2014 Earnings investment picks
Adjusted EBITDA Increases 27% to $77.3 Million Adjusted Basic Net Income per Share Doubles to $0.36 $159.8 Million in Free Cash Flow Delivered in the Quarter SANTA MONICA, Calif.
Sign-up for LIONSGATE REPORTS RESULTS FOR FIRST QUARTER 2015 investment picks
Strong RevPAR Increase of 7.7% for All Hotels for the Second Quarter DALLAS , Aug.
Sign-up for Ashford Trust Reports Second Quarter 2014 Results investment picks
MILL VALLEY, Calif.
Sign-up for Redwood Trust Reports Second Quarter 2014 Results investment picks
ALISO VIEJO, Calif.
Sign-up for Sunstone Hotel Investors Reports Results For Second Quarter 2014 investment picks
BRAINTREE, Mass., Aug.
Sign-up for Altra Industrial Motion Corp. to Present at Jefferies 2014 Global Industrials Conference investment picks
Total revenue of $32.3 million grew 33% year-over-year CHARLESTON, S.C., Aug.
Sign-up for Benefitfocus Announces Second Quarter 2014 Financial Results investment picks
BERKELEY, Calif.
Sign-up for Annie's Reports First Quarter Financial Results, Reaffirms Full Year Guidance investment picks
VANCOUVER , Aug.
Sign-up for International Tower Hill Mines Files 2014 Second Quarter Financial Results investment picks
Net Income (Loss) - $(0.3) million Adjusted; $12.1 million GAAP Revenue - $122.8 million Adjusted (Education down 19%, Enterprise up 45% year-over-year); $137.5 million GAAP Adjusted EBITDA - $10.3 million Unveiled new SMART kapp™ capture board Launched SMART amp™ and Notebook Advantage education software Launched SMART Board 6065 education interactive flat panel CALGARY, Alberta, Aug.
Sign-up for SMART Reports First Quarter 2015 Financial Results investment picks
Recent Highlights BURLINGTON, Mass., Aug.
Sign-up for Flexion Therapeutics Reports Second-Quarter 2014 Financial Results investment picks
Engility Holdings, Inc. (NYSE: EGL) today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Engility Reports Second Quarter 2014 Results investment picks
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing PRX302 for the treatment of the symptoms of benign prostatic hyperplasia (BPH, enlarged prostate) and for the treatment of localized prostate cancer, today announced financial results and recent key operational and financial highlights for the three and six months ended June 30, 2014.
Sign-up for Sophiris Bio Reports Second Quarter Financial Results and Key Operational and Financial Highlights investment picks
DALLAS, Aug.
Sign-up for Speed Commerce Reports Fiscal First Quarter 2015 Results investment picks
Ireland Inc. ( OTCBB: IRLD ) today announced that the Company will host an investor update conference call on Thursday, August 14, 2014 at 1:30 p.m. PDT (4:30 p.m. EDT). The purpose of this call is to update investors regarding the progress and developments related to the gold and silver extraction process at the Columbus Project and its on-site pilot plant located in Nevada.
Sign-up for Ireland Inc. to Host Q2 Results Conference Call on Thursday, August 14, 2014 investment picks
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, reported financial results for the second quarter ended June 30, 2014, and also provided an overview of certain corporate accomplishments and plans.
Sign-up for Verastem Reports Second Quarter 2014 Financial and Corporate Results investment picks
Net loss of $70,000, reduced $1.6 million from same period last year Oculus owns two million shares of Ruthigen (Nasdaq:RTGN) Net worth of $13.4 million, up $10.8 million from June 30, 2013 Cash position of $5 million with $64,000 in debt Conference Call Begins at 4:30 p.m. (EDT) Today PETALUMA, Calif., Aug.
Sign-up for Oculus Innovative Sciences Reports Revenues of $3.4 Million and Net Loss of $70,000 for First Quarter of Fiscal 2015 investment picks
Record Revenue of $98.1 Million in Q2 2014 and Sequential Revenue Growth of 14% Versus Q1 2014 Adjusted EBITDA* Reaches $6.5 Million; Strong Sequential Growth from Q1 2014 Launched WISE™, Global Eagle's Wireless Inflight Entertainment Solution, on Philippine Airlines Partnered with Boeing in Effort to Provide Line-fit Offerability on Boeing 737 and 787 Finalized Acquisition of All Remaining Outstanding Shares of AIA; Expect Significant Integration Synergies Beginning in 2H 2014 Strong Balance Sheet With $215 Million in Cash and Less Than $4 Million in Debt at Quarter End LOS ANGELES, Aug.
Sign-up for Global Eagle Entertainment Reports Second Quarter 2014 Results investment picks
BOSTON, Aug.
Sign-up for EnerNOC Reports Results for Second Quarter of 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G019670-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/7/11G019670/Vivus-751277076657.jpg MOUNTAIN VIEW, CA--(Marketwired - August 07, 2014) - VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia ® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the second quarter ended June 30, 2014 and provided a business update.
Sign-up for VIVUS Reports Second Quarter 2014 Financial Results investment picks
LA JOLLA, Calif.
Sign-up for Regulus to Present at the Wedbush Life Sciences Management Access Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ZIOPHARM Reports Second-Quarter 2014 Financial Results and Reviews Recent Activities to Regulus to Present at the Wedbush Life Sciences Management Access Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices